PL361702A1 - Nowe krystaliczne postaci N-hydroksy-2(S)-metylo-5-etoksy-metoksy-4(S)-[N-(4-fenoksyfenylokarbonylo)amino]pentanamidu, sposób ich wytwarzania oraz leki zawierajace je jako składnik aktywny - Google Patents
Nowe krystaliczne postaci N-hydroksy-2(S)-metylo-5-etoksy-metoksy-4(S)-[N-(4-fenoksyfenylokarbonylo)amino]pentanamidu, sposób ich wytwarzania oraz leki zawierajace je jako składnik aktywnyInfo
- Publication number
- PL361702A1 PL361702A1 PL01361702A PL36170201A PL361702A1 PL 361702 A1 PL361702 A1 PL 361702A1 PL 01361702 A PL01361702 A PL 01361702A PL 36170201 A PL36170201 A PL 36170201A PL 361702 A1 PL361702 A1 PL 361702A1
- Authority
- PL
- Poland
- Prior art keywords
- crystals
- phenoxyphenylcarbonyl
- ethoxymethoxy
- pentanamide
- hydroxy
- Prior art date
Links
- 239000013078 crystal Substances 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- HDWWQELUBWGQGA-WMZOPIPTSA-N n-[(2s,4s)-1-(ethoxymethoxy)-5-(hydroxyamino)-4-methyl-5-oxopentan-2-yl]-4-phenoxybenzamide Chemical compound C1=CC(C(=O)N[C@@H](C[C@H](C)C(=O)NO)COCOCC)=CC=C1OC1=CC=CC=C1 HDWWQELUBWGQGA-WMZOPIPTSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/50—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000273445 | 2000-09-08 | ||
| PCT/JP2001/007775 WO2002020467A1 (fr) | 2000-09-08 | 2001-09-07 | Nouveaux cristaux de n-hydroxy-2(s)-methyl-5-ethoxymethoxy-4(s)-[n-(4-phenoxyphenylcarbonyl)amino]pentanamide, leur procede de production et medicaments contenant ces cristaux en tant que substance active |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL361702A1 true PL361702A1 (pl) | 2004-10-04 |
Family
ID=18759384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL01361702A PL361702A1 (pl) | 2000-09-08 | 2001-09-07 | Nowe krystaliczne postaci N-hydroksy-2(S)-metylo-5-etoksy-metoksy-4(S)-[N-(4-fenoksyfenylokarbonylo)amino]pentanamidu, sposób ich wytwarzania oraz leki zawierajace je jako składnik aktywny |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20040152785A1 (pl) |
| EP (1) | EP1316547A4 (pl) |
| KR (1) | KR20030059125A (pl) |
| CN (1) | CN1473148A (pl) |
| AU (1) | AU2001284477A1 (pl) |
| BR (1) | BR0113760A (pl) |
| CA (1) | CA2419744A1 (pl) |
| CZ (1) | CZ2003636A3 (pl) |
| HU (1) | HUP0302928A3 (pl) |
| IL (1) | IL154625A0 (pl) |
| MX (1) | MXPA03001985A (pl) |
| NO (1) | NO20031030L (pl) |
| PL (1) | PL361702A1 (pl) |
| RU (1) | RU2003106391A (pl) |
| WO (1) | WO2002020467A1 (pl) |
| ZA (1) | ZA200301869B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0100761D0 (en) * | 2001-01-11 | 2001-02-21 | Biocompatibles Ltd | Drug delivery from stents |
| RU2352558C2 (ru) * | 2003-10-21 | 2009-04-20 | Уорнер-Ламберт Компани Ллс | Полиморфная форма n-[(r)-2,3-дигидроксипропокси]-3,4-дифтор-2-(2-фтор-4 йодфениламино)бензамида |
| US7713541B1 (en) * | 2006-11-21 | 2010-05-11 | Abbott Cardiovascular Systems Inc. | Zwitterionic terpolymers, method of making and use on medical devices |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1024134A4 (en) * | 1997-10-09 | 2003-05-14 | Ono Pharmaceutical Co | DERIVATIVES OF AMINOBUTANIC ACID |
-
2001
- 2001-09-07 CA CA002419744A patent/CA2419744A1/en not_active Abandoned
- 2001-09-07 AU AU2001284477A patent/AU2001284477A1/en not_active Abandoned
- 2001-09-07 EP EP01963509A patent/EP1316547A4/en not_active Withdrawn
- 2001-09-07 CN CNA018185525A patent/CN1473148A/zh active Pending
- 2001-09-07 WO PCT/JP2001/007775 patent/WO2002020467A1/ja not_active Ceased
- 2001-09-07 BR BR0113760-3A patent/BR0113760A/pt not_active Application Discontinuation
- 2001-09-07 IL IL15462501A patent/IL154625A0/xx unknown
- 2001-09-07 MX MXPA03001985A patent/MXPA03001985A/es not_active Application Discontinuation
- 2001-09-07 HU HU0302928A patent/HUP0302928A3/hu unknown
- 2001-09-07 US US10/362,290 patent/US20040152785A1/en not_active Abandoned
- 2001-09-07 CZ CZ2003636A patent/CZ2003636A3/cs unknown
- 2001-09-07 RU RU2003106391/04A patent/RU2003106391A/ru not_active Application Discontinuation
- 2001-09-07 PL PL01361702A patent/PL361702A1/pl unknown
- 2001-09-07 KR KR10-2003-7003266A patent/KR20030059125A/ko not_active Withdrawn
-
2003
- 2003-03-05 NO NO20031030A patent/NO20031030L/no not_active Application Discontinuation
- 2003-03-06 ZA ZA200301869A patent/ZA200301869B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001284477A1 (en) | 2002-03-22 |
| CA2419744A1 (en) | 2003-02-26 |
| IL154625A0 (en) | 2003-09-17 |
| HUP0302928A2 (hu) | 2003-12-29 |
| BR0113760A (pt) | 2003-07-15 |
| NO20031030D0 (no) | 2003-03-05 |
| NO20031030L (no) | 2003-05-08 |
| CZ2003636A3 (cs) | 2003-08-13 |
| RU2003106391A (ru) | 2004-07-27 |
| EP1316547A1 (en) | 2003-06-04 |
| CN1473148A (zh) | 2004-02-04 |
| HUP0302928A3 (en) | 2005-03-29 |
| KR20030059125A (ko) | 2003-07-07 |
| MXPA03001985A (es) | 2003-09-05 |
| US20040152785A1 (en) | 2004-08-05 |
| WO2002020467A1 (fr) | 2002-03-14 |
| ZA200301869B (en) | 2004-06-25 |
| EP1316547A4 (en) | 2005-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0201646A3 (en) | Novel alpha-amino acid derivatives, process for producing them and pharmaceutical compositions containing them | |
| WO2000055125A3 (en) | N-cyanomethyl amides as protease inhibitors | |
| SI1417206T1 (sl) | Novi H piridazin onski derivati farmacevtski sestavki ki jih vsebujejo in postopek za pripravo aktivne sestavine | |
| WO2004055006A8 (en) | Novel compounds having selective inhibiting effect at gsk3 | |
| IL192233A0 (en) | Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a subsituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing them | |
| AU4143300A (en) | Cyclic amide compounds, process for the preparation of the same and uses thereof | |
| AU2001260455A1 (en) | Cyclic amino acid derivatives useful as pharmaceutical agents | |
| WO2001079174A8 (en) | A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds | |
| AU2001267886A1 (en) | Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them | |
| BG104243A (en) | Method for the synthesis of quinoline derivatives | |
| HUP0600084A2 (en) | Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient | |
| IL154625A0 (en) | Novel crystals of n-hydroxy-2 (s)-methyl-5-ethoxymethoxy-4-(s)-[n-(4-phenoxyphenylcarbonyl) amino] pentanamide, process for their production and medicines containing the crystals as the active ingredient | |
| BG107407A (en) | Novel polymorph v of torasemide | |
| AU2001284476A1 (en) | Novel crystals of 1,3,4-oxadiazole derivative, process for producing the crystals and medicines containing the same as the active ingredient | |
| HUP0203270A3 (en) | Hydroxamic acid derivative as inhibitor of the formation of human cd23, process for its preparation and pharmaceutical compositions containing the same | |
| GB0306088D0 (en) | Process for the preparation of a cosmetic active | |
| PL357466A1 (pl) | Optycznie czynne pochodne 2-aminotetralinowe, sposoby ich wytwarzania i zastosowanie terapeutyczne zawierających je kompozycji farmaceutycznych | |
| AU2002364804A8 (en) | Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses | |
| SI1146044T1 (en) | CNS active cyclobuta-indole carboxamide derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| GB0306081D0 (en) | Process for the preparation of a cosmetic active | |
| GB2393185B (en) | A novel process for the preparation of 3,3'-azo-bis(6-hydroxybenzoic acid) and its derivatives | |
| AU2880701A (en) | Process for preparation of optically active n-substituted azetidine-2-carboxylicacids | |
| HUP9902682A3 (en) | Stable non-hygroscopic crystalline form of n-n-[n-(4-piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds, process for producing them and pharmaceutical compositions containing them | |
| AU2510801A (en) | Purification of n,n-substituted amides of the trifluoroacetic acid | |
| HUP9801086A3 (en) | Benzofurane derivatives, pharmaceutical compositions containing them as active ingredient process for producing the active ingredient and intermediates of them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |